3CPM TRICORDER-3L / Electrogastrography EGG / ONLY APPROVED TEST / ACCURATELY CHARACTERIZE GASTROINTESTINAL MOTILITY DISORDERS / GASTROPARESIS / FUNCTIONAL DYSPESIA || Electroviscerography EVG / ONLY NON-INVASIVE DIAGNOSTIC TEST FOR ENDOMETRIOSIS / 100% SENSITIVITY / 100% SELECTIVITY || Non-Invasive, simple 45-minute test. / AI derived patented technology. / Subtype disease to optimize treatment. / Personalize diagnosis and therapy.

GASTROPARESIS AND DYSPEPSIA CAN BE CURED. TRICORDER-3L EGG can subtype and identify the 25% of Gastroparesis and Dyspepsia that is curable.

SUBTYPE OTHER GASTROINTESTINAL DISORDERS. TRICORDER-3L real-time data objectively defines the cause of disease as well as the most successful treatment option

EASY TO USE, EASY TO READ. Evidence based Auto Diagnostic Interpretation and Reporting.

FOR PATIENTS: Resolution of Disease. Control of Symptoms. FOR PHYSICIANS AND FACILITIES: Improved patient outcomes. Increased patient satisfaction. Positive Cashflow.

TRICORDER-3L: Next Generation Diagnostics for Gastrointestinal Disease

Building upon 30 years of advances in artificial intelligence, device development and medical simulation derived hardware and software integration, the 3CPM Company pioneered future advancements in Electrogastrography and Electroviscerography embodied in the Tricorder-3L.

Miniaturization of hardware components coupled with evidence-based AI-driven software diagnostics and interpretation gave rise to the next generation technology which serves as the basis for current and developing platforms in Electrogastrography and Electroviscerography.

Leading the way forward is 3CPM’s proprietary matured technology, completely automated signal acquisition and AI based automation of diagnostic and recommended therapeutic applications.

Electrogastrography EGG

ONLY APPROVED TEST
ACCURATELY CHARACTERIZE GASTROINTESTINAL MOTILITY DISORDERS
GASTROPARESIS
FUNCTIONAL DYSPESIA

Electroviscerography EVG

ONLY NON-INVASIVE DIAGNOSTIC TEST FOR ENDOMETRIOSIS
100% SENSITIVITY
100% SELECTIVITY

Features

Non-Invasive, simple 45-minute test.
AI derived patented technology.
Subtype disease to optimize treatment.
Personalize diagnosis and therapy.

TRICORDER-3L Attributes:

Non-invasive and very simple to perform 45 minute test
Patented breakthrough technology
Personalized diagnosis of gastrointestinal disorders
Subtyping myoelectrical activity to optimize treatment outcomes
Defining pathways to control or cure previously uncurable illnesses
Accurate, Timely and Objective diagnosis of:
- dyspepsia
- gastroparesis
- endometriosis
- reflux
- motility disorder
- pyloric dysfunction
- nausea
- vomiting
- bloating
- abdominal distension
- abdominal pain